EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Subchronic Toxicity Study of Nitric Oxide Nanobubble Injection in Sprague Dawley Rats

Dody Novrial, Nor Sri Inayati, Nur Signa Aini Gumilas, Dhadhang Wahyu Kurniawan, Sutiman Bambang Sumitro

Applied Biosciences · 01.06.2026 · 5 (2) · 45

DOI: 10.3390/applbiosci5020045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biosciences, online erschienen am 01.06.2026. Verfasst von Dody Novrial und 4 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indonesia Molecular Innovation Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The development of nanobubble technology has expanded to various gas molecules, such as nitric oxide (NO). NO donors have been frequently used for both therapeutic and diagnostic purposes. However, the use of NO in nanoformulations has received little attention thus far. This research aimed to assess the subchronic toxicity of NO nanobubbles in a preclinical study design.

Methods

Ninety days of subchronic toxicity testing based on modified OECD guidelines in Sprague Dawley rats was used in this study to assess potential adverse effects of intravenous administration of NO nanobubbles (NONBs). Hematological factors, serum biochemistry, and histology of the liver, kidney, heart, lung, and spleen were investigated.

Results

The intravenous NONB injection trial using graded doses of 0.01 mL, 0.04 mL, and 0.06 mL resulted in no deaths during the 90-day treatment period. However, liver disturbance and electrolyte imbalance emerged. This condition was supported by histological findings in the liver and kidney, which showed potential reversible damage, and persistent hemorrhage of the spleen.

Conclusions

Intravenous administration of NONBs at a dose of up to 0.06 mL in this subchronic toxicity test remains safe. Further studies with adjustments to the test formulation are highly encouraged before the clinical trial stage in humans.

Förderung

  • Indonesia Molecular Innovation Foundation

Zitieren

APA

Novrial, D., Inayati, N. S., Gumilas, N. S. A., Kurniawan, D. W., & Sumitro, S. B. (2026). Subchronic Toxicity Study of Nitric Oxide Nanobubble Injection in Sprague Dawley Rats. Applied Biosciences, 5(2), 45. https://doi.org/10.3390/applbiosci5020045

Vancouver

Novrial D, Inayati NS, Gumilas NSA, Kurniawan DW, Sumitro SB. Subchronic Toxicity Study of Nitric Oxide Nanobubble Injection in Sprague Dawley Rats. Applied Biosciences. 2026;5(2):45. doi:10.3390/applbiosci5020045

BibTeX
@article{Novrial2026,
  author = {Novrial, Dody and Inayati, Nor Sri and Gumilas, Nur Signa Aini and Kurniawan, Dhadhang Wahyu and Sumitro, Sutiman Bambang},
  title = {Subchronic Toxicity Study of Nitric Oxide Nanobubble Injection in Sprague Dawley Rats},
  journal = {Applied Biosciences},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {45},
  doi = {10.3390/applbiosci5020045}
}
Kostenlos starten →